The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis


It has been previously found that the blockade of metabotropic glutamate receptor type 5 (mGluR5) protects against hepatic ischemia/reperfusion injury and acetaminophen toxicity. The role of mGluR5 in NAFLD has not yet been elucidated. Here, we evaluated the effects of mGluR5 blockade in an in vitro model of steatosis. HepG2 cells were pre-incubated for 12 h with an mGluR5 agonist, a negative allosteric modulator (DHPG and MPEP, respectively) or vehicle, then treated with 1.5 mM oleate/palmitate (O/P) for another 12 h. Cell viability was evaluated with the MTT assay; fat accumulation was measured using the fluorescent dye nile red; SREBP-1, PPAR-α, iNOS and Caspase-3 protein expression were evaluated by Western blot; NFkB activity was evaluated as pNFkB/NFkB ratio. mGluR5 modulation did not alter cell viability in O/P-incubated cells; MPEP prevented intracellular lipid accumulation in O/P treated cells; MPEP administration was also associated with a reversion of O/P-induced changes in SREBP-1 and PPAR-α expression, involved in free fatty acid (FFA) metabolism and uptake. No changes were observed in iNOS and Caspase-3 expression, or in NFkB activity. In conclusion, mGluR5 pharmacological blockade reduced fat accumulation in HepG2 cells incubated with O/P, probably by modulating the expression of SREBP-1 and PPAR-α.



PlumX Metrics


Download data is not yet available.
Supporting Agencies
Ministry of Health - Project
NAFLD, mGluR5, MPEP, oleate/palmitate, HepG2, SREBP-1, PPAR-α
  • Abstract views: 211

  • PDF: 114
  • Supplementary: 15
  • HTML: 0
How to Cite
Ferrigno, A., Berardo, C., Di Pasqua, L. G., Cagna, M., Siciliano, V., Richelmi, P., & Vairetti, M. (2020). The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an <em>in vitro</em&gt; model of benign steatosis. European Journal of Histochemistry, 64(4).